Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Sulaiman Al Habib Medical Services GroupSAU:4013 +0.61%93 Return-on-Tangible-Equity is 25.40% as of Mar. 2026, which is 14% below its 10-year median of 29.43. GuruFocus rates SAU:4013 with a GF Score™ of 93/100 and a GF Value™ of ﷼397.09 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 577 Healthcare Providers & Services companies, Dr Sulaiman Al Habib Medical Services Group ranks better than 77.3% on this metric.
SAU:4013's Return-on-Tangible-Equity is ranked better than 77.3% of 577
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs SAU:4013: 30.63
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Dr Sulaiman Al Habib Medical Services Group Return-on-Tangible-Equity Related Terms
Dr Sulaiman Al Habib Medical Services Group Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group Return-on-Tangible-Equity Chart
Dr Sulaiman Al Habib Medical Services Group Annual Data
SAU:4013 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Dr Sulaiman Al Habib Medical Services Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Sulaiman Al Habib Medical Services Group Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Sulaiman Al Habib Medical Services Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Dr Sulaiman Al Habib Medical Services Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 25.40% mean?
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a Return-on-Tangible-Equity of 25.40% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. This is 14% below median its historical median of 29.43. Over the past decade, Dr Sulaiman Al Habib Medical Services Group's Return-on-Tangible-Equity has ranged from 19.81 to 33.90. According to the industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #131 out of 577 companies in the Healthcare Providers & Services industry, placing it in the top 22.7%.
Is Dr Sulaiman Al Habib Medical Services Group's Return-on-Tangible-Equity too high?
Dr Sulaiman Al Habib Medical Services Group's current Return-on-Tangible-Equity of 25.40% is 14% below median its 10-year median of 29.43. Over the past 10 years, this metric has ranged from a low of 19.81 to a high of 33.90. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.13. Dr Sulaiman Al Habib Medical Services Group's value of 25.40% is 150.7% above this industry median. Based on the distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #131 out of 577 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #131 out of 577 companies for Return-on-Tangible-Equity. This places Dr Sulaiman Al Habib Medical Services Group in the top 23% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.13. Dr Sulaiman Al Habib Medical Services Group's value of 25.40% is 150.7% above this benchmark. Historically, Dr Sulaiman Al Habib Medical Services Group's own Return-on-Tangible-Equity has ranged from 19.81 to 33.90 over the past decade. While the company's 10-year median is 29.43 vs. the industry median of 10.13, Dr Sulaiman Al Habib Medical Services Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Sulaiman Al Habib Medical Services Group's current Return-on-Tangible-Equity of 25.40% is 150.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Sulaiman Al Habib Medical Services Group's current Return-on-Tangible-Equity is 25.40%, which is 14% below median its own 10-year median of 29.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼397.09, compared to a current price of ﷼215.30 — trading 45.8% below its estimated fair value. The current Return-on-Tangible-Equity is 25.40%, which is 14% below median its 10-year median of 29.43 and 150.7% above the Healthcare Providers & Services industry median of 10.13. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current Return-on-Tangible-Equity is 25.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued.
The current stock price of ﷼215.30 is trading 45.8% below its estimated GF Value™ of ﷼397.09.
GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.
Key valuation signals for SAU:4013:
Return-on-Tangible-Equity: 25.40% (14% below median its 10-year median of 29.43)
GF Value™: ﷼397.09 vs. price of ﷼215.30 (45.8% below fair value)
Industry Position: 150.7% above the Healthcare Providers & Services median (#131 of 577)
No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Sulaiman Al Habib Medical Services Group Business Description
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
93GF Score
Get the complete analysis for SAU:4013
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4013 has been successfully added to your 
